Information Library

Results for: Central Nervous System - Product Development & Commercialization - Phase II/III

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • Exclusive Report From Scientific American

    Hear from the Experts — November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Advancing Clinical Research in Alzheimer's Disease

    White Paper — October 18, 2010
    This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010.

  • The Evolving Role of Neuroimaging in Future AD Clinical Trials

    Presentation — September 21, 2010
    Download the slides from Philip Scheltens, MD VU Medical Center, Amsterdam recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials

  • Behavior as an Outcome in Disease Modifying AD Trials

    Video — August 6, 2010
    Watch the video of Jeffrey Cummings, M.D. of Cleveland Clinic recent presentation, Behaviors as an Outcome in Disease Modifying AD Trials from the Quintiles Symposium at ICAD 2010

  • Anticipating the Challenge

    Case Study — March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    Case Study — March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    Brochure — July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences